TrialCancer medicine2020

Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial.

Moe Tsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.